Overall rank by patents
#26,233
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 10 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
Ecofibre holds 10 US patents across 10 technology areas, rank #26,233 of 50,000 tracked assignees.
Ecofibre USA Inc. has been granted 10 US utility patents between 2021 and 2025, placing Ecofibre USA Inc. at rank #26,233 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.9 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Ecofibre USA Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Ecofibre sits between Easepal Enterprises Limited (10 patents, rank #26,229) and Edlund Company, Llc (10 patents, rank #26,237) - the closest US assignees by grant volume. The composite Innovation Score of 46.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ecofibre USA Inc.'s 10.9 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ecofibre USA Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Easepal Enterprises Limited
10 patents
Eberhard-Karls-Universität Tübingen Universitätsklinikum
10 patents
Echo Pixel, Inc.
10 patents
Echo Ridge, LLC
10 patents
Ecore International Inc.
10 patents
Edenlux Corporation
10 patents
Edison Opto Corporation
10 patents
Edlund Company, LLC
10 patents
Ecofibre USA Inc.
10 patents
What this shows Ecofibre holds 10 patents at rank #26,233, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Ecofibre's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 10.0% |
| 2023 | 1 | 10.0% |
| 2024 | 5 | 50.0% |
| 2025 | 3 | 30.0% |
Top 10 of 10 technology areas
Overall rank by patents
#26,233
Across all tracked assignees
46.0 out of 100
How to use this portfolio
Ecofibre's 10 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.